BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36924264)

  • 1. Modeling unmeasured baseline information in observational time-to-event data subject to delayed study entry.
    Stegherr R; Beyersmann J; Bramlage P; Bluhmki T
    Stat Methods Med Res; 2023 May; 32(5):1021-1032. PubMed ID: 36924264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of baseline hazards in joint modeling of longitudinal and time-to-event cancer survival data.
    Hari A; Jinto EG; Dennis D; Krishna KMNJ; George PS; Roshni S; Mathew A
    Stat Appl Genet Mol Biol; 2024 Jan; 23(1):. PubMed ID: 38736398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates.
    Chen Q; May RC; Ibrahim JG; Chu H; Cole SR
    Stat Med; 2014 Nov; 33(26):4560-76. PubMed ID: 24947785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.
    Crowther MJ; Andersson TM; Lambert PC; Abrams KR; Humphreys K
    Stat Med; 2016 Mar; 35(7):1193-209. PubMed ID: 26514596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian joint ordinal and survival modeling for breast cancer risk assessment.
    Armero C; Forné C; Rué M; Forte A; Perpiñán H; Gómez G; Baré M
    Stat Med; 2016 Dec; 35(28):5267-5282. PubMed ID: 27523800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible parametric approach for analyzing arbitrarily censored data that are potentially subject to left truncation under the proportional hazards model.
    Withana Gamage PW; McMahan CS; Wang L
    Lifetime Data Anal; 2023 Jan; 29(1):188-212. PubMed ID: 36208362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
    Pennell ML; Whitmore GA; Ting Lee ML
    Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease.
    Lee C; Betensky RA;
    Stat Med; 2018 Mar; 37(6):914-932. PubMed ID: 29266591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian design of clinical trials using joint models for longitudinal and time-to-event data.
    Xu J; Psioda MA; Ibrahim JG
    Biostatistics; 2022 Apr; 23(2):591-608. PubMed ID: 33155038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MODELING LEFT-TRUNCATED AND RIGHT-CENSORED SURVIVAL DATA WITH LONGITUDINAL COVARIATES.
    Su YR; Wang JL
    Ann Stat; 2012 Jun; 40(3):1465-1488. PubMed ID: 29479122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study.
    Ngwa JS; Cabral HJ; Cheng DM; Gagnon DR; LaValley MP; Cupples LA
    BMC Med Res Methodol; 2021 Feb; 21(1):29. PubMed ID: 33568059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A joint model for survival and longitudinal data measured with error.
    Wulfsohn MS; Tsiatis AA
    Biometrics; 1997 Mar; 53(1):330-9. PubMed ID: 9147598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian dynamic regression models for interval censored survival data with application to children dental health.
    Wang X; Chen MH; Yan J
    Lifetime Data Anal; 2013 Jul; 19(3):297-316. PubMed ID: 23389549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian quantile regression-based nonlinear mixed-effects joint models for time-to-event and longitudinal data with multiple features.
    Huang Y; Chen J
    Stat Med; 2016 Dec; 35(30):5666-5685. PubMed ID: 27592848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint modeling of event time and nonignorable missing longitudinal data.
    Dupuy JF; Mesbah M
    Lifetime Data Anal; 2002 Jun; 8(2):99-115. PubMed ID: 12048867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulating survival data with predefined censoring rates for proportional hazards models.
    Wan F
    Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantile regression-based Bayesian joint modeling analysis of longitudinal-survival data, with application to an AIDS cohort study.
    Zhang H; Huang Y
    Lifetime Data Anal; 2020 Apr; 26(2):339-368. PubMed ID: 31140028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian joint modeling of longitudinal measurements and time-to-event data using robust distributions.
    Baghfalaki T; Ganjali M; Hashemi R
    J Biopharm Stat; 2014; 24(4):834-55. PubMed ID: 24697192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis.
    Schluchter MD; Piccorelli AV
    Stat Methods Med Res; 2019 May; 28(5):1489-1507. PubMed ID: 29618290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.